Who
Andrew Stewart Plump
President, R&D
Company insider
Files Form 4 as: President, R&D, Takeda Pharmaceutical Company.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $10.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 27 Apr 2026
- Last trade
- 2 Sep 2026
- Last filed
- 3 Sep 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Sep 2026filed 3 Sep 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Sold | $2.1M116,191 at $18.49 | filing |
| 2 Sep 2026filed 3 Sep 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Sold | $2.1M116,191 at $18.49 | filing |
| 19 Aug 2026filed 21 Aug 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Sold | $363K19,651 at $18.49 | filing |
| 19 Aug 2026filed 21 Aug 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Sold | $363K19,651 at $18.49 | filing |
| 10 Aug 2026filed 12 Aug 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Sold | $2.8M165,393 at $17.10 | filing |
| 10 Aug 2026filed 12 Aug 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Sold | $2.8M165,393 at $17.10 | filing |
| 1 Jul 2026filed 6 Jul 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Code A | —125,390 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Code A | —125,390 at $0.00 | filing |
| 27 Apr 2026filed 28 Apr 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Code A | —212,470 at $0.00 | filing |
| 27 Apr 2026filed 28 Apr 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Code A | —212,470 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.